Rep. Dave Schweikert (R-AZ) thinks weight loss drugs could lead to lower obesity rates, which could lead to less government spending on health care. It might not be so simple.
A recent Food and Drug Administration decision that makes naloxone available without a prescription may increase the drug’s accessibility. But cost could be a barrier